QNTM Stock Summary and Trading Ideas (Quantum Biopharma Ltd. - Class B Subordinate Voting Shares | NASDAQ:QNTM)

Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.

Quantum Biopharma Ltd. - Class B Subordinate Voting Shares trades on the NASDAQ stock market under the symbol QNTM.

As of March 3, 2025, QNTM stock price declined to $4.30 with 86,005 million shares trading.

QNTM has a beta of 3.24, meaning it tends to be more sensitive to market movements. QNTM has a correlation of 0.04 to the broad based SPY ETF.

QNTM has a market cap of $8.24 million. This is considered a Sub-Micro Cap stock.

Last quarter Quantum Biopharma Ltd. - Class B Subordinate Voting Shares reported $0 in Revenue and -$4.37 earnings per share. This fell short of revenue expectation by $-710,000 and missed earnings estimates by -$.47.

QNTM support price is $3.91 and resistance is $5.19 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that QNTM shares will trade within this expected range on the day.